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Abstract 
Introduction: Following trainging, Reactive Oxygen Spices (ROS) play a crucial role in the 
regulation of signaling pathways and adaptions in skeletal muscle, including mitochondrial 
biogenesis and improvement in insulin sensitivity a ROS-induced physical activity can also 
stimulate myokine production in skeletal muscle. The aim of this work was hence to investigate the 
role of NADPH Oxidase-2 (NOX2), the main source of ROS generation, in contracting muscle in IL-
15 gene expression, as well as anychanges in PGC-1, as a key regulator of mitochondrial 
biogenesis, following a period of High-intensity Interval Training (HIIT). Materials and Methods:
Mice were divided into four groups: Wild type (WT) control (WTc) and training (WTt), NOX-2 
deficient (ND) control (NDc) and training (NDt). Training groups performed 6-week HIIT, including 2-
min running intervals with 100% of their maximum running speed and 2-min rest with 30% of this 
speed for a total of 60 min; speed was increased 1m/min each week. IL-15, PGC-1 and NOX2 
mRNA levels in gastrocnemius muscle were analyzed using Real time. Results: Basal levels of IL-
15 mRNA in NDc group were significantly lower than the other groups. Relative gene expression in 
WTc, WTt, NDc and NDt changed for IL-15 1, 1.15, 0.49 and 0.99 and for PGC-1 1, 1.73. 0.76 and 1.4 
times, respectively in WTt. Post-training muscle PGC-1 mRNA levels increased significantly. 
Conclusion: Results indicate that IL-15 gene expression in mouse skeletal muscle is dependent on 
NOX2. And apparently NOX2 deficiency may result in impaired PGC-1 expression and 
subsequently diminished mitochondrial biogenesis. 
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Abstract 
Introduction: Following trainging, Reactive Oxygen Spices (ROS) play a crucial role in the 
regulation of signaling pathways and adaptions in skeletal muscle, including mitochondrial 
biogenesis and improvement in insulin sensitivity a ROS-induced physical activity can also 
stimulate myokine production in skeletal muscle. The aim of this work was hence to investigate the 
role of NADPH Oxidase-2 (NOX2), the main source of ROS generation, in contracting muscle in IL-
15 gene expression, as well as anychanges in PGC-1, as a key regulator of mitochondrial 
biogenesis, following a period of High-intensity Interval Training (HIIT). Materials and Methods:
Mice were divided into four groups: Wild type (WT) control (WTc) and training (WTt), NOX-2 
deficient (ND) control (NDc) and training (NDt). Training groups performed 6-week HIIT, including 2-
min running intervals with 100% of their maximum running speed and 2-min rest with 30% of this 
speed for a total of 60 min; speed was increased 1m/min each week. IL-15, PGC-1 and NOX2 
mRNA levels in gastrocnemius muscle were analyzed using Real time. Results: Basal levels of IL-
15 mRNA in NDc group were significantly lower than the other groups. Relative gene expression in 
WTc, WTt, NDc and NDt changed for IL-15 1, 1.15, 0.49 and 0.99 and for PGC-1 1, 1.73. 0.76 and 1.4 
times, respectively in WTt. Post-training muscle PGC-1 mRNA levels increased significantly. 
Conclusion: Results indicate that IL-15 gene expression in mouse skeletal muscle is dependent on 
NOX2. And apparently NOX2 deficiency may result in impaired PGC-1 expression and 
subsequently diminished mitochondrial biogenesis. 
 
Keywords: Reactive oxygen spices, NADPH Oxidase 2, IL-15, skeletal muscle, High intensity interval 
training 
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